HomeCompareOCFCP vs PFE

OCFCP vs PFE: Dividend Comparison 2026

OCFCP yields 7.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCFCP wins by $11.4K in total portfolio value
10 years
OCFCP
OCFCP
● Live price
7.00%
Share price
$25.00
Annual div
$1.75
5Y div CAGR
17.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60.9K
Annual income
$9,095.84
Full OCFCP calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — OCFCP vs PFE

📍 OCFCP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCFCPPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCFCP + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCFCP pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCFCP
Annual income on $10K today (after 15% tax)
$595.00/yr
After 10yr DRIP, annual income (after tax)
$7,731.46/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $14,588.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCFCP + PFE for your $10,000?

OCFCP: 50%PFE: 50%
100% PFE50/50100% OCFCP
Portfolio after 10yr
$55.2K
Annual income
$17,677.28/yr
Blended yield
32.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

OCFCP
Analyst Ratings
1
Strong
2
Buy
3
Hold
Consensus: Hold
Altman Z
1.2
Piotroski
7/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCFCP buys
0
PFE buys
0
No recent congressional trades found for OCFCP or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCFCPPFE
Forward yield7.00%6.13%
Annual dividend / share$1.75$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR17.3%13.2%
Portfolio after 10y$60.9K$49.6K
Annual income after 10y$9,095.84$26,258.71
Total dividends collected$34.4K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: OCFCP vs PFE ($10,000, DRIP)

YearOCFCP PortfolioOCFCP Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,521$821.10$9,153$693.39+$2.4KOCFCP
2$13,365$1,037.07$8,593$849.25+$4.8KOCFCP
3$15,619$1,318.81$8,336$1,066.78+$7.3KOCFCP
4$18,402$1,689.64$8,437$1,384.80+$10.0KOCFCP
5$21,872$2,182.32$9,013$1,875.40+$12.9KOCFCP
6$26,247$2,843.58$10,306$2,680.72+$15.9KOCFCP
7$31,825$3,740.79$12,820$4,101.38+$19.0KOCFCP
8$39,025$4,972.42$17,673$6,826.70+$21.4KOCFCP
9$48,441$6,684.34$27,543$12,591.86+$20.9KOCFCP
10$60,928$9,095.84$49,560$26,258.71+$11.4KOCFCP

OCFCP vs PFE: Complete Analysis 2026

OCFCPStock

OceanFirst Financial Corp. operates as the bank holding company for OceanFirst Bank N.A. that provides community banking services. It accepts money market accounts, savings accounts, interest-bearing checking accounts, non-interest-bearing demand deposits, and time deposits to retail, government, and business customers. The company also offers commercial real estate, multi-family, land loans, construction, and commercial and industrial loans; fixed-rate and adjustable-rate mortgage loans that are secured by one-to-four family residences; and consumer loans, such as home equity loans and lines of credit, student loans, overdraft line of credit, loans on savings accounts, and other consumer loans. In addition, it invests in mortgage-backed securities, securities issued by the U.S. Government and agencies, corporate securities, and other investments. Further, the company offers bankcard, wealth management, and trust and asset management services; and sells alternative investment products and life insurance products. As of December 31, 2021, it operated through its branch office in Toms River; administrative office located in Red Bank and Mount Laurel; 46 additional branch offices and four deposit production facilities located throughout central and southern New Jersey; and commercial loan production offices in New Jersey, New York City, the Philadelphia area, Baltimore, and Boston. The company was founded in 1902 and is based in Red Bank, New Jersey.

Full OCFCP Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this OCFCP vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCFCP vs SCHDOCFCP vs JEPIOCFCP vs OOCFCP vs KOOCFCP vs MAINOCFCP vs JNJOCFCP vs MRKOCFCP vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.